Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Castaño

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|April 17, 2012
Cardiovascular phenotype of nonalcoholic fatty liver disease: hanging the paradigm about the role of distant toxic fat accumulation on vascular diseaseSilvia Sookoian, Gustavo O Castaño, Carlos J Pirola
Revista Clinica Espanola|April 3, 2007
[Vegetarian diets; effect on health]D de Luis Román, R Aller, O Castaño
Gut|September 13, 2013
Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individualsSilvia Sookoian, Gustavo O Castaño, Carlos J Pirola
Hepatology (Baltimore, Md.)|August 23, 2014
PNPLA3 I148M variant is associated with metabolic stress-response phenotype in patients with nonalcoholic fatty liver diseaseSilvia Sookoian, Gustavo O Castaño, Carlos J Pirola
Journal of the Royal Society, Interface|August 1, 2008
Biomaterials in orthopaedicsM Navarro, A Michiardi, O Castaño, et al.
Journal of Materials Science. Materials in Medicine|April 14, 2010
Injectable and fast resorbable calcium phosphate cement for body-setting bone graftsI Rajzer, O Castaño, E Engel, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2016
Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver diseaseS Sookoian, D Flichman, G O Castaño, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndromeCarlos J Pirola, Tomas Fernández Gianotti, Gustavo O Castaño, et al.
Journal of Internal Medicine|July 8, 2020
Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver diseaseC J Pirola, M Garaycoechea, D Flichman, et al.
Revista De Enfermeria (Barcelona, Spain)|July 1, 1984
[Nursing time in intensive care]M Garrido Macías, A Vázquez Navarrete, O Castaño Dios, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|April 17, 2012
Cardiovascular phenotype of nonalcoholic fatty liver disease: hanging the paradigm about the role of distant toxic fat accumulation on vascular diseaseSilvia Sookoian, Gustavo O Castaño, Carlos J Pirola
Revista Clinica Espanola|April 3, 2007
[Vegetarian diets; effect on health]D de Luis Román, R Aller, O Castaño
Gut|September 13, 2013
Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individualsSilvia Sookoian, Gustavo O Castaño, Carlos J Pirola
Hepatology (Baltimore, Md.)|August 23, 2014
PNPLA3 I148M variant is associated with metabolic stress-response phenotype in patients with nonalcoholic fatty liver diseaseSilvia Sookoian, Gustavo O Castaño, Carlos J Pirola
Journal of the Royal Society, Interface|August 1, 2008
Biomaterials in orthopaedicsM Navarro, A Michiardi, O Castaño, et al.
Journal of Materials Science. Materials in Medicine|April 14, 2010
Injectable and fast resorbable calcium phosphate cement for body-setting bone graftsI Rajzer, O Castaño, E Engel, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2016
Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver diseaseS Sookoian, D Flichman, G O Castaño, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndromeCarlos J Pirola, Tomas Fernández Gianotti, Gustavo O Castaño, et al.
Journal of Internal Medicine|July 8, 2020
Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver diseaseC J Pirola, M Garaycoechea, D Flichman, et al.
Revista De Enfermeria (Barcelona, Spain)|July 1, 1984
[Nursing time in intensive care]M Garrido Macías, A Vázquez Navarrete, O Castaño Dios, et al.
Pageof 4